Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare form of pulmonary hypertension (PH), a disease associated with abnormally high pressure in the blood vessels of the lungs, caused by the formation of blood clots. CTEPH also can be referred to as group 4 PH, the World Health Organization classification that…
Search results for:
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) is a rare form of pulmonary hypertension (PH) caused by blood clots obstructing the pulmonary arteries. It is also known as group 4 PH. CTEPH can lead to right-sided heart failure and is often underdiagnosed due to symptoms similar to other PH types. Early diagnosis allows for surgical treatment.
AI-generated summaries are for informational use only, based on content from multiple pages. They may not reflect full context. For complete details, see the original sources. Consult a qualified healthcare professional for medical advice.
Social Clips
Thromboembolic Pulmonary Hypertension
“In this video, from the Texas Heart Institute, meet Deborah Meyers, MD, and her patient Trasetta Terry, a retired pharmacist who tells us about her experience with thromboembolic pulmonary hypertension.” Keep up to date on all the latest PH news here: https://bit.ly/20LXxHN…
New research is shedding light on the progression of CTEPH. A novel study on chronic thromboembolic pulmonary hypertension (CTEPH), entitled “Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients” published in the European Respiratory Journal by Dr. Diana Zabini, part…
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) has been identified as one of the major causes of acute pulmonary hypertension (PH). This condition is characterized by a progressively dangerous accumulation of blood clots within pulmonary vasculature, which leads to PH and can eventually cause right-sided heart failure. It…
The Pulmonary Hypertension Association (PHA) is planning a series of events for November, Pulmonary Hypertension Awareness Month, including a daylong focus on chronic thromboembolic pulmonary hypertension (CTEPH), a form of pulmonary hypertension (PH) that results from blood clots in the lungs. Events planned for CTEPH Awareness Day, Nov. 15, include promoting information about the two…
People with chronic thromboembolic pulmonary hypertension (CTEPH) are more likely to have a depressive temperament, finds a Japanese study, “Depressive Status in Patients With Chronic Thromboembolic Pulmonary Hypertension” that appeared in the Circulation Journal. CTEPH is a progressive disease characterized by increasing pulmonary vascular resistance. Although the underlying…
In this video from PHA Canada, meet Dr. Sanjay Mehta. Dr. Mehta is a CTEPH-treating doctor and in this clip shared in 2014, he discusses some important information on CTEPH and pulmonary hypertension. Read the latest updates on pulmonary hypertension: https://bit.ly/1K4oewk…
Social Clips
CTEPH: What You Need to Know
https://www.youtube.com/watch?v=W2YLo6U1uFU Pulmonary hypertension (PH) is a rare lung disease that refers to an increase in blood pressure in the pulmonary arteries. Unfortunately, there is still no known cure available to end PH, but research has been evolving and doctors and scientists have been discovering some new ways to approach this…
https://vimeo.com/184579437 In this video from Elsevier Pharma Solutions, Professor Marc Humbert discusses the diagnostic processes for pulmonary hypertension and chronic thromboembolic pulmonary hypertension (CTEPH)—which is a curable form of the disease. RELATED: A study find international diagnosis and management of CTEPH is inadequate. Prof. Hubert explains that CTEPH is…
Researchers have developed a computer tomography pulmonary embolism residua index (CTPER-index) that may prove to be a useful tool for diagnosis and treatment decisions regarding chronic thromboembolic pulmonary hypertension and dyspnea. The research paper, “Computed tomography pulmonary embolism residua index (CTPER-index): a simple tool for pulmonary embolism residua description,” was…
Social Clips
The Treatment Options for CTEPH
In this video from the Fondazione Internazionale Menarini, Dr. Vittorio Pengo discusses his presentation of the pathophysiology and treatment of chronic thromboembolic pulmonary hypertension (CTEPH). MORE: Find out how doctors diagnosed pulmonary hypertension and CTEPH. Dr. Pengo explains that CTEPH is a treatable disease that occurs in 0.5…
Social Clips
#phaware: What’s CTEPH?
Are you #phaware? March is Blood Clot Awareness Month. CTEPH is the only type of PH that is potentially curable. 1 in 25 people who have had a pulmonary embolism (PE) could develop CTEPH. A VQ scan is a critical tool in the diagnosis of CTEPH. Engage for a cure.